Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 1
1997 1
1999 1
2001 2
2003 1
2004 1
2005 8
2006 4
2007 4
2008 5
2009 7
2010 9
2011 9
2012 6
2013 19
2014 12
2015 15
2016 23
2017 23
2018 33
2019 28
2020 35
2021 28
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment.
Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Löwenberg M, de Boer NK, Oldenburg B, Srivastava N, Jansen JM, Bodelier AGL, West RL, de Vries AC, Haans JJL, de Jong D, Hoentjen F, Pierik MJ; Dutch Initiative on Crohn and Colitis (ICC). Biemans VBC, et al. Among authors: de boer nk. Aliment Pharmacol Ther. 2020 Jul;52(1):123-134. doi: 10.1111/apt.15745. Epub 2020 May 22. Aliment Pharmacol Ther. 2020. PMID: 32441396 Free PMC article.
Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.
Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F. Biemans VBC, et al. Among authors: de boer nkh. J Crohns Colitis. 2020 Jan 1;14(1):33-45. doi: 10.1093/ecco-jcc/jjz119. J Crohns Colitis. 2020. PMID: 31219157 Free PMC article.
[Oral manifestations of Crohn's disease].
Tan CXW, de Boer NKH, Brand HS. Tan CXW, et al. Among authors: de boer nkh. Ned Tijdschr Tandheelkd. 2018 Jan;125(1):15-20. doi: 10.5177/ntvt.2018.01.17174. Ned Tijdschr Tandheelkd. 2018. PMID: 29377966 Review. Dutch.
Microscopic colitis.
Mulder CJ, Harkema IM, Meijer JW, De Boer NK. Mulder CJ, et al. Among authors: de boer nk. Rom J Gastroenterol. 2004 Jun;13(2):113-7. Rom J Gastroenterol. 2004. PMID: 15229775 Review.
[Oral manifestations of ulcerative colitis].
Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Tan CXW, et al. Among authors: de boer nkh. Ned Tijdschr Tandheelkd. 2017 May;124(5):243-247. doi: 10.5177/ntvt.2017.05.16217. Ned Tijdschr Tandheelkd. 2017. PMID: 28501878 Review. Dutch.
[Coeliac disease and dentistry].
van Gils T, de Boer NK, Bouma G. van Gils T, et al. Among authors: de boer nk. Ned Tijdschr Tandheelkd. 2015 Sep;122(9):443-8. doi: 10.5177/ntvt.2015.09.15145. Ned Tijdschr Tandheelkd. 2015. PMID: 26397103 Review. Dutch.
Discontinuation rate of azathioprine.
Crouwel F, Buiter HJC, de Boer NK. Crouwel F, et al. Among authors: de boer nk. Liver Int. 2020 Dec;40(12):3141. doi: 10.1111/liv.14574. Epub 2020 Jul 5. Liver Int. 2020. PMID: 32627355 No abstract available.
Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide.
Crouwel F, Simsek M, Mulder CJ, Buiter HJ, De Boer NK. Crouwel F, et al. Among authors: de boer nk. J Gastrointestin Liver Dis. 2020 Dec 13;29(4):637-645. doi: 10.15403/jgld-2765. J Gastrointestin Liver Dis. 2020. PMID: 33331335 Free article. Review.
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
de Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel JF, Lopez A, Beaugerie L, Marinaki AM, van Bodegraven AA, Neurath MF. de Boer NKH, et al. J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181. J Crohns Colitis. 2018. PMID: 29293971 Review.
251 results